-
Novo Nordisk A/S (NVO $47.86)
-
Vanguard FTSE Developed Markets ETF (VEA $62.04)
-
ASML Holding N.V. (ASML $1,099.47)
-
iShares MSCI Intl Quality Factor ETF (IQLT $45.09)
Q: I've owned IQLT for a few years now. I've noticed that the VEA top holdings are quite similar to IQLT, but at a significantly reduced MER. Is it really worth paying that much more to continue to hold IQLT? Maybe you have better insight on the differences between the two than I do (?)